| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 90946 |
Deferoxamine-DBCO |
173 |
zyl |
2024-11-29 |
| 90947 |
金刚烷-聚丙烯酸/β环糊精的支化聚乙烯亚胺 PAA‑AD/PEI‑βCD |
169 |
h |
2024-11-29 |
| 90948 |
p-NH2-Bn-DTPA |
149 |
zyl |
2024-11-29 |
| 90949 |
依多曲肽，204318-14-9，DOTA-(Tyr3)-Octreotide |
232 |
wyh |
2024-11-29 |
| 90950 |
NOTA-p-NCSA-Me-Tetrazine-amine |
159 |
zyl |
2024-11-29 |
| 90951 |
C13-DBCO的用途与应用 |
188 |
wyh |
2024-11-29 |
| 90952 |
2C-p-NETA-NCS-Fmoc-D-赖氨酸 |
132 |
zyl |
2024-11-29 |
| 90953 |
DOTA-Glu-[cyclo (Arg-Gly-Asp-d-Phe-Lys)] |
201 |
wyh |
2024-11-29 |
| 90954 |
金刚烷修饰超支化聚丙烯酸酯 HBPA-AD |
213 |
h |
2024-11-29 |
| 90955 |
NOTA-CONH-PEG23-NH-CO-CH2-CH2-Mal |
177 |
zyl |
2024-11-29 |
| 90956 |
金刚烷修饰六面体倍半硅氧烷 AD-POSS |
259 |
h |
2024-11-29 |
| 90957 |
大环配体化合物Gd-DOTA-RGD ，NOTA/NOTA-PEG-多肽 |
158 |
wyh |
2024-11-29 |
| 90958 |
金刚烷修饰纳米抗体7D12 AD-7D12 |
235 |
h |
2024-11-29 |
| 90959 |
TOC奥曲肽修饰 ; 68Ga-DOTA-Ingr |
212 |
wyh |
2024-11-29 |
| 90960 |
AD-PEG-FITC 金刚烷聚已内酯异硫氰酸荧光素 |
184 |
h |
2024-11-29 |
| 90961 |
偶氮苯修饰半乳糖化聚乙二醇 Az-PEG-Gal |
252 |
h |
2024-11-29 |
| 90962 |
DOTA/DFO-PSMA-617 ， DOTA偶联达尔-PSMA-617复合体 |
342 |
kx |
2024-11-29 |
| 90963 |
金刚烷修饰的1,2-二氧环丁烷 |
254 |
h |
2024-11-29 |
| 90964 |
DOTA-Ala-Ala-Tyr-COOH的结构组成 |
186 |
wyh |
2024-11-29 |
| 90965 |
cyclo(RGDFK(DOTA))的性质与功能 |
200 |
wyh |
2024-11-29 |
| 90966 |
DOTA-SiMPs ，介孔硅纳米结构(SiMPs)共轭四氮杂环十二烷四乙酸(DOTA) |
197 |
kx |
2024-11-29 |
| 90967 |
FITC标记TAT穿膜肽 ；Gd-DTPA-ACPP |
183 |
wyh |
2024-11-29 |
| 90968 |
DOTA-Octreotide ，DOTA-奥曲肽 |
157 |
wyh |
2024-11-29 |
| 90969 |
单克隆抗体B72.3偶联DOTA ，DOTA-B72.3 |
204 |
kx |
2024-11-29 |
| 90970 |
螯合剂多肽cyclo(RGDFK(DOTA)) ，DOTA-c(RGDfK) |
178 |
wyh |
2024-11-29 |
| 90971 |
NOTA-(COOt-Bu)2 cas:1161415-28-6 |
220 |
zyl |
2024-11-29 |
| 90972 |
DOTA-JR10多肽的功能特点 |
214 |
wyh |
2024-11-29 |
| 90973 |
Biotin-Gd-DOTA ；生物素修饰的钆 |
145 |
wyh |
2024-11-29 |
| 90974 |
DOTA-CC9 ，细胞膜的环肽CC9偶联DOTA |
323 |
kx |
2024-11-29 |
| 90975 |
1，4，7，10-四氮杂环十二烷-N.N '，N "，N " '-四乙酸(H4DOTA) |
403 |
kx |
2024-11-29 |
| 90976 |
NOTA-bis-COOH-Me-Tetrazine 大环配体NOTA-三羧酸-甲基四嗪 |
157 |
zyl |
2024-11-29 |
| 90977 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[(diphosphonomethyl)amino]-2-oxoethyl]- 定制 |
177 |
zcy |
2024-11-29 |
| 90978 |
DOTA-pNO2Phe-c[DCys-Tyr-DTrp-Lys-Thr-Cys]-DTyr-NH2 |
273 |
kx |
2024-11-29 |
| 90979 |
MeTz-PEG7-NOTA 甲基四嗪-聚乙二醇-大环化合物 Me-Tetrazine-PEG7-NOTA |
131 |
zyl |
2024-11-29 |
| 90980 |
DOTAGA-四叔丁酯，306776-79-4，DOTAGA-(COOt-Bu)4 |
241 |
zcy |
2024-11-29 |
| 90981 |
金刚烷改性氰酸酯树脂 AD-CE |
237 |
h |
2024-11-29 |
| 90982 |
DOTA-Tyr-Lys-DOTA ；DOTA-酪氨酸-赖氨酸-DOTA |
171 |
wyh |
2024-11-29 |
| 90983 |
HA-DOTA tate ， DOTA-3-碘-Tyr 3-奥曲肽 ， HA-DOTATATE |
157 |
kx |
2024-11-29 |
| 90984 |
NOTA-E(cRGDfK)2 ， NOTA修饰多肽 |
153 |
wyh |
2024-11-29 |
| 90985 |
叠氮-NOTA cas:2125661-92-7 NOTA-Azide/N3 |
165 |
zyl |
2024-11-29 |
| 90986 |
金刚烷改性壳聚糖 AD-CS |
216 |
h |
2024-11-29 |
| 90987 |
DOTA-c(RGDfK) ， 螯合物前体多肽 |
222 |
wyh |
2024-11-29 |
| 90988 |
DOTA-Lys-PEG(4)[D-Phe(6) |
174 |
kx |
2024-11-29 |
| 90989 |
葫芦[7]脲包裹盐酸金刚烷胺 CB[7]-AD |
214 |
h |
2024-11-29 |
| 90990 |
L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide, 2,2,2-trifluoroacetate (1:) 定制 |
147 |
zcy |
2024-11-29 |
齐岳微信公众号
官方微信
库存查询